Clinical Trials Directory

Trials / Completed

CompletedNCT05609565

Intrathecal Prilocaine and Adductor Canal Block vs Intrathecal Bupivacaine Alone for Ambulatory Knee Arthroscopy

Hybrid Anesthesia for Ambulatory Knee Arthroscopy Using Intrathecal Prilocaine and Adductor Canal Block vs Intrathecal Bupivacaine Alone: a Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

\- Although bupivacaine is safe and has a low rate of transient neurologic symptoms, the prolonged sensory and motor block is a drawback for day-case spinal anesthesia.Intrathecal hyperbaric prilocaine causes a much shorter motor block, with a similar onset time and lower inter-individual variability in motor block duration. Furthermore, the peripheral nerve block is used as an adjunct to the spinal anesthesia to prolong the surgical anesthetic conditions.

Conditions

Interventions

TypeNameDescription
DRUGspinal anesthesia with hyperbaric prilocaine+adductor canal block (ACB) with bupivacainespinal anesthesia with hyperbaric prilocaine+adductor canal block (ACB) with bupivacaine
DRUGspinal anesthesia with bupivacainespinal anesthesia with bupivacaine

Timeline

Start date
2022-11-15
Primary completion
2024-09-30
Completion
2024-09-30
First posted
2022-11-08
Last updated
2024-11-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05609565. Inclusion in this directory is not an endorsement.